Paret, Michal
Katzenellenbogen, Guy
Zilberman, Tal
Stein, Michal
Margalit, Ili
Yahav, Dafna https://orcid.org/0000-0003-3181-9791
Article History
Received: 13 September 2025
Accepted: 1 April 2026
First Online: 2 May 2026
Declarations
:
: Dafna Yahav declares a collaborative retrospective study with Pfizer, and an investigator-initiated study funded by Shionogi (all funding paid to the institution); Michal Paret, Guy Katzenellenbogen, Michal Stein, Ili Margalit, Tal Zilberman have nothing to disclose. Dafna Yahav is an Editorial Board Member of Infectious Diseases and Therapy . Dafna Yahav was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.